Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07566260

Stress and Menstrual Health

The goal of this experimental study is to determine how stressors that do not directly impact energy state or energy demands (hereafter called "non-energetic stressors") affect reproductive health in pre-menopausal women. It aims to do this by answering the following main questions: Do non-energetic stressors create a stress response? How does the stress response impact sex hormone concentration and thus menstrual dysfunction? If stress caused by non-energetic stressors does impact sex hormone concentration, does it do so primarily at the level of the brain or the level of the ovary? Participants will be enrolled in this study for 6 months. For two of these months, they will undergo a short stress intervention and provide samples to measure hormone concentration and total energy expenditure.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Duke University

Durham, North Carolina, 27708, United States

Location status: Recruiting

Location contact

Mary Joy

CONTACT

[email protected]

7249317802

About this study

The Reproductive Suppression Model posits that due to the high cost and failure rate of human reproduction, the female body maximizes lifetime reproductive fitness by suppressing reproduction during poor conditions (where likelihood of offspring survival is low) until conditions are more favorable. The hormonal mechanism for this suppression when calories are scarce and the female body is in low energy availability (LEA) has been studied. However, the mechanism for this suppression in the presence of stressors unrelated to low energy availability, but which could still negatively impact offspring survival, is much less clear. The investigators define such stressors, which do not impact energy state or energetic demands, as "non-energetic stressors." Thus, the aim of this study is to determine if non-energetic stressors drive reproductive suppression in humans. The investigators will assess this by testing the impact of a stress intervention on the stress hormones cortisol and norepinephrine, and in turn if the levels of these stress hormones predict the levels of sex hormones associated with the menstrual cycle. Finally, the investigators will assess if changes in stress hormones change total and basal energy expenditure.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult pre-menopausal females, 18-45 years old
  • Habitually sedentary (less than 60 minutes MVPA/week) for Exercise cohort

Exclusion criteria

  • Individuals on hormonal birth control (oral contraception, injection, implant, or intrauterine device)
  • Individuals with incidence in the last 6 months of childbirth, lactation, pregnancy, or functional hypothalamic amenorrhea (FHA)
  • Individuals with reproductive disorders (e.g. endometriosis, polycystic ovarian syndrome (PCOS))
  • Individuals taking thyroid medications
  • Individuals who have undergone or are undergoing menopause
  • MVPA >60 min/week (for Exercise cohort)

Treatment and study plan

heat stress

Other

Stress-Heat participants will undergo supervised 40-min sessions in a 70-80˚C sauna

Sleep stress

Other

Stress-Sleep participants will be asked to sleep for between 4 and 6 hours per night, with compliance monitored via their activity monitors and self-reported sleep diaries. Participants will be requested to maintain normal wake cycles without midday sleep.

Exercise stress

Other

Stress-Exercise participants will come to the Pontzer Lab to complete a one-hour cycling workout on a Lode Corival CPET ergometer/exercise bike at 60-75% predicted maximum heart rate.

Primary outcomes

  1. Total daily energy expenditure (TDEE)

    Time frame: Baseline (Month 2), Intervention (Month 4)

    TDEE (kcal) will be measured over a 7-day period during the Baseline and first Intervention month using the doubly-labeled water (DLW) method. DLW is a safe and reliable method for capturing free-living TDEE and has been validated for human studies. The DLW method adds a known amount of stable isotopes, oxygen-18 (18O) and deuterium (2H), to a participant's total body water (TBW) via ingestion and then measures the depletion rate of these isotopes as they are removed from the body via urine and exhalation.

  2. Basal metabolic rate (BMR)

    Time frame: Baseline (Month 2), Control (Month 3), Intervention (Months 4-5), and Follow-up (Month 6)

    BMR (kcal/d) will be estimated via indirect calorimetry. Participants will be asked to come in for a lab visit on a day of their choice within 2-7 days post-ovulation prior to consuming breakfast or any non-water beverage and after having refrained from exercise for 24 hours pre-measurement. Participants will lie on an exam bed in the Pontzer Lab and have a clear plastic hood connected to a COSMED Quark RMR machine placed over their head for approximately 25-30 minutes. This hood will collect exhaled air, which will be measured for CO2 production to estimate BMR.

  3. Sex hormone concentration (estradiol)

    Time frame: Baseline (Month 2), Control (Month 3), Intervention (Months 4-5), and Follow-up (Month 6)

    Samples will be assayed via enzyme-linked immunosorbent assay (ELISA) in the Pontzer Lab.

  4. Sex hormone concentration (progesterone)

    Time frame: Baseline (Month 2), Control (Month 3), Intervention (Months 4-5), and Follow-up (Month 6)

    Samples will be assayed via enzyme-linked immunosorbent assay (ELISA) in the Pontzer Lab.

Secondary outcomes

  1. Stress hormone concentration (norepinephrine)

    Time frame: Baseline (Month 2), Control (Month 3), Intervention (Months 4-5), and Follow-up (Month 6)

    Samples will be assayed via enzyme-linked immunosorbent assay (ELISA) in the Pontzer Lab.

  2. Stress hormone concentration (cortisol)

    Time frame: Baseline (Month 2), Control (Month 3), Intervention (Months 4-5), and Follow-up (Month 6)

    Samples will be assayed via enzyme-linked immunosorbent assay (ELISA) in the Pontzer Lab.

  3. Stress hormone concentration (salivary alpha-amylase)

    Time frame: Baseline (Month 2), Control (Month 3), Intervention (Months 4-5), and Follow-up (Month 6)

    Samples will be assayed via enzyme-linked immunosorbent assay (ELISA) in the Pontzer Lab.

  4. Sex hormone concentration (luteinizing hormone (LH))

    Time frame: Baseline (Month 2), Control (Month 3), Intervention (Months 4-5), and Follow-up (Month 6)

    Samples will be assayed via enzyme-linked immunosorbent assay (ELISA) in the Pontzer Lab.

  5. Sex hormone concentration (follicle-stimulating hormone (FSH))

    Time frame: Baseline (Month 2), Control (Month 3), Intervention (Months 4-5), and Follow-up (Month 6)

    Samples will be assayed via enzyme-linked immunosorbent assay (ELISA) in the Pontzer Lab.

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

The Influence of Non-energetic Stressors on Human Menstrual Function

Important dates

Study start
2026
Primary completion
2028
Study completion
2029
First posted
May 5, 2026
Registry last updated
Jun 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.